Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Tabor

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Food and Drug Administration Requirements for Clinical Studies in Pediatric PatientsEdward Tabor
The New England Journal of Medicine|April 14, 2021
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent PericarditisEdward Tabor
Transfusion|November 15, 2002
NAT screening of blood and plasma donations: evolution of technology and regulatory policyEdward Tabor, Jay S Epstein
Science (New York, N.Y.)|November 8, 2008
Bacteria by the bookEdward Tabor, Louis B Rice
Journal of Medical Virology|September 5, 2002
Drift in the hypervariable region of the hepatitis C virus during 27 years in two patientsGuang Gao, Zelma Buskell, Leonard Seeff, et al.
Transfusion|July 1, 2005
SEN virus: epidemiology and characteristics of a transfusion-transmitted virusJun Akiba, Takeji Umemura, Harvey J Alter, et al.
International Journal of Molecular Medicine|November 18, 2004
Truncated hepatitis C virus core protein encoded in hepatocellular carcinomasRin Yamaguchi, Seiya Momosaki, Guang Gao, et al.
Transfusion|February 14, 2004
HCV core antigen as an alternative to NAT to detect HCV viremiaChristina A Raker, Edward Tabor, Akihiko Okayama, et al.
Transfusion|May 22, 2003
Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infectionRobin Biswas, Edward Tabor, Chu Chieh Hsia, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Food and Drug Administration Requirements for Clinical Studies in Pediatric PatientsEdward Tabor
The New England Journal of Medicine|April 14, 2021
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent PericarditisEdward Tabor
Transfusion|November 15, 2002
NAT screening of blood and plasma donations: evolution of technology and regulatory policyEdward Tabor, Jay S Epstein
Science (New York, N.Y.)|November 8, 2008
Bacteria by the bookEdward Tabor, Louis B Rice
Journal of Medical Virology|September 5, 2002
Drift in the hypervariable region of the hepatitis C virus during 27 years in two patientsGuang Gao, Zelma Buskell, Leonard Seeff, et al.
Transfusion|July 1, 2005
SEN virus: epidemiology and characteristics of a transfusion-transmitted virusJun Akiba, Takeji Umemura, Harvey J Alter, et al.
International Journal of Molecular Medicine|November 18, 2004
Truncated hepatitis C virus core protein encoded in hepatocellular carcinomasRin Yamaguchi, Seiya Momosaki, Guang Gao, et al.
Transfusion|February 14, 2004
HCV core antigen as an alternative to NAT to detect HCV viremiaChristina A Raker, Edward Tabor, Akihiko Okayama, et al.
Transfusion|May 22, 2003
Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infectionRobin Biswas, Edward Tabor, Chu Chieh Hsia, et al.
Pageof 2